Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.89EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.89EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.89ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.89ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
M.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
M.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
M.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
M.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
M.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
M.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
M.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
M.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.333EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.333EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.333ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.333ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.333EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.333EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.333ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.333ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.429EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.429EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.429ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.429ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.429EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.429EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.429ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.429ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AH.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AH.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AH.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AH.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AH.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AH.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.327EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.327EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.327ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-13655.5Germany
B.1.1.327ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.327EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
B.1.1.327EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.327ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4486.95China
B.1.1.327ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.396EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.396EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.396ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.396ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.396EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.396EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used